NanoLogix, Inc. is pleased to announce that major advances have been made in the rapid detection of Anthrax utilizing the NanoLogix BioNanoChannel Device.
here appears to be an opportunity to determine the viability and persistence of Anthrax spores much faster than current methods due to the unique rapid culturing aspects of the BNC technology. "Superb progress has been made in our research efforts simulating Anthrax spore growth through the use of non-hazardous spores. This research has the potential to immediately translate to the ability to conduct rapid Anthrax viability testing," said CEO Bret Barnhizer. "We have been impressed with the Department of Defense's dedication to finding the best solution for the security of our country in the event of a biological attack. We look forward to making a major contribution in this area by providing a method by which the government is able to determine the effectiveness of their decontamination efforts in hours rather than days."